Publications by authors named "Robert Hegeman"

Claim this Profile
A
A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer.
Sailaja Kamaraju, Amy M Fowler, Sergey Tarima, Lubna N Chaudhary, Mark E Burkard, Robert Hegeman

Clin Breast Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study.
Kari B Wisinski, Wei Xu, Amye J Tevaarwerk, Sandeep Saha, KyungMann Kim, Robert Hegeman

Clin Breast Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network.
Natalie Callander, Stephanie Markovina, Jens Eickhoff, Paul Hutson, Toby Campbell, Robert Hegeman

Cancer Chemother Pharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study.
Mark E Burkard, Kari B Wisinski, Uchenna O Njiaju, Sarahmaria Donohue, Robert Hegeman

Clin Breast Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newer therapies in advanced prostate cancer.
Robert B Hegeman, Glenn Liu, George Wilding, Douglas G McNeel

Clin Prostate Cancer· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis